Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.1174 http://scihub22266oqcxt.onion/10.7759/cureus.1174 C5436886!5436886!28533992     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cureus ä ; 9 (4): ä Nephropedia Template TP {{tp|p=28533992|t=ä. Ambulatory Heart Failure Monitoring: A Systemic Review |pdf=|usr=}}{{28533992}} gab.com Text Ambulatory Heart Failure Monitoring: A Systemic Review JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=28533992 #FOAvip Heart failure (HF) is one of the leading causes of morbidity and mortality and has a large effect on the country?s economy. Although there have been major advances in HF monitoring, including more advanced pharmacological management and device-based therapy, HF-related mortality remains high. It is important to monitor HF so that HF-related hospitalization and mortality can be prevented. Due to the lower sensitivity of clinical features and biochemical markers, as well as the failure of telemonitoring in early detection of HF, more advanced techniques have been sought to more accurately predict impending HF, in order to address timely pharmacological management and prevent heart failure hospitalization (HFH). Device-based therapy has passed through various stages and culminated in the recently introduced CardioMEMSTM (St. Jude Medical, Inc., Saint Paul, Minnesota). CardioMEMSTM is a wireless pulmonary artery pressure (PAP) monitoring device, which continuously monitors PAP and transmits data to a healthcare provider. It rapidly identifies changes in intracardiac pressure and allows timely pharmacological management. CardioMEMSTM showed a higher reduction of HFH compared to any other devices. Twit Text FOAVip Ambulatory Heart Failure Monitoring: A Systemic Review ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=28533992 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28533992 #FOAvip English Wikipedia <ref>{{Cite pmid|28533992}}</ref> Ambulatory Heart Failure Monitoring: A Systemic Review #MMPMID28533992 Mangi MA; Rehman H; Rafique M; Illovsky M Cureus ä[]; 9 (4): ä PMID28533992show ga Heart failure (HF) is one of the leading causes of morbidity and mortality and has a large effect on the country?s economy. Although there have been major advances in HF monitoring, including more advanced pharmacological management and device-based therapy, HF-related mortality remains high. It is important to monitor HF so that HF-related hospitalization and mortality can be prevented. Due to the lower sensitivity of clinical features and biochemical markers, as well as the failure of telemonitoring in early detection of HF, more advanced techniques have been sought to more accurately predict impending HF, in order to address timely pharmacological management and prevent heart failure hospitalization (HFH). Device-based therapy has passed through various stages and culminated in the recently introduced CardioMEMSTM (St. Jude Medical, Inc., Saint Paul, Minnesota). CardioMEMSTM is a wireless pulmonary artery pressure (PAP) monitoring device, which continuously monitors PAP and transmits data to a healthcare provider. It rapidly identifies changes in intracardiac pressure and allows timely pharmacological management. CardioMEMSTM showed a higher reduction of HFH compared to any other devices. äAmbulatory Heart Failure Monitoring: A Systemic Review (epmc).pdf DeepDyve Pubget Overpricing